X-48601914-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BS2
The NM_001347217.2(WDR13):c.962C>T(p.Ala321Val) variant causes a missense change. The variant allele was found at a frequency of 0.00001 in 1,198,367 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.0000083 ( 0 hom. 5 hem. )
Consequence
WDR13
NM_001347217.2 missense
NM_001347217.2 missense
Scores
8
8
Clinical Significance
Conservation
PhyloP100: 6.84
Genes affected
WDR13 (HGNC:14352): (WD repeat domain 13) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by Gly-His and Trp-Asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. A similar protein in mouse is thought to be a negative regulator of the pancreatic beta cell proliferation. Mice lacking this gene exhibit increased pancreatic islet mass and higher serum insulin levels, and are mildly obese. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), WDR13. . Gene score misZ 3.2948 (greater than the threshold 3.09). GenCC has associacion of gene with intellectual disability.
BS2
High Hemizygotes in GnomAdExome4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR13 | NM_001347217.2 | c.962C>T | p.Ala321Val | missense_variant | 7/10 | ENST00000376729.10 | NP_001334146.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR13 | ENST00000376729.10 | c.962C>T | p.Ala321Val | missense_variant | 7/10 | 5 | NM_001347217.2 | ENSP00000365919 | P1 | |
WDR13 | ENST00000218056.9 | c.962C>T | p.Ala321Val | missense_variant | 6/9 | 1 | ENSP00000218056 | P1 | ||
WDR13 | ENST00000479279.5 | n.1829C>T | non_coding_transcript_exon_variant | 5/8 | 1 | |||||
WDR13 | ENST00000482760.3 | c.206C>T | p.Ala69Val | missense_variant | 2/5 | 3 | ENSP00000483191 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112698Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34840
GnomAD3 genomes
AF:
AC:
3
AN:
112698
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
34840
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000829 AC: 9AN: 1085669Hom.: 0 Cov.: 31 AF XY: 0.0000142 AC XY: 5AN XY: 353061
GnomAD4 exome
AF:
AC:
9
AN:
1085669
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
353061
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000266 AC: 3AN: 112698Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34840
GnomAD4 genome
AF:
AC:
3
AN:
112698
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
34840
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.962C>T (p.A321V) alteration is located in exon 6 (coding exon 6) of the WDR13 gene. This alteration results from a C to T substitution at nucleotide position 962, causing the alanine (A) at amino acid position 321 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Uncertain
Sift
Benign
T;T;.
Sift4G
Benign
T;T;T
Vest4
MutPred
Loss of catalytic residue at A321 (P = 0.0396);Loss of catalytic residue at A321 (P = 0.0396);.;
MVP
MPC
1.1
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at